3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
7
Neoplasms
6
Breast Neoplasms
3
Pancreatic Neoplasms
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Fatigue
1
Disease
1
Colonic Neoplasms
1
Interventions
Cisplatin
6
Gemcitabine
5
Oxaliplatin
3
Irinotecan
3
durvalumab
2
Folfox protocol
2
Fluorouracil
2
Capecitabine
2
Bevacizumab
2
zanidatamab
1
trastuzumab deruxtecan
1
toripalimab
1
pembrolizumab
1
niraparib
1
neratinib
1
ivosidenib
1
futibatinib
1
fludarabine
1
envafolimab
1
encorafenib
1
brigimadlin
1
binimetinib
1
Trastuzumab
1
Pemetrexed
1
Nivolumab
1
Leucovorin
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Exercise
×
30 days
×
Clear all
No trials found.